OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
APR-246—The Mutant TP53 Reactivator—Increases the Effectiveness of Berberine and Modified Berberines to Inhibit the Proliferation of Pancreatic Cancer Cells
James A. McCubrey, Stephen L. Abrams, Linda S. Steelman, et al.
Biomolecules (2022) Vol. 12, Iss. 2, pp. 276-276
Open Access | Times Cited: 6
James A. McCubrey, Stephen L. Abrams, Linda S. Steelman, et al.
Biomolecules (2022) Vol. 12, Iss. 2, pp. 276-276
Open Access | Times Cited: 6
Showing 6 citing articles:
Pharmacokinetic of berberine, the main constituent of Berberis vulgaris L.: A comprehensive review
Arian Khoshandam, Mohsen Imenshahidi, Hossein Hosseinzadeh
Phytotherapy Research (2022) Vol. 36, Iss. 11, pp. 4063-4079
Closed Access | Times Cited: 36
Arian Khoshandam, Mohsen Imenshahidi, Hossein Hosseinzadeh
Phytotherapy Research (2022) Vol. 36, Iss. 11, pp. 4063-4079
Closed Access | Times Cited: 36
Effects of TP53 Mutations and miRs on Immune Responses in the Tumor Microenvironment Important in Pancreatic Cancer Progression
James A. McCubrey, Li V. Yang, Stephen L. Abrams, et al.
Cells (2022) Vol. 11, Iss. 14, pp. 2155-2155
Open Access | Times Cited: 30
James A. McCubrey, Li V. Yang, Stephen L. Abrams, et al.
Cells (2022) Vol. 11, Iss. 14, pp. 2155-2155
Open Access | Times Cited: 30
Driver Mutations in Pancreatic Cancer and Opportunities for Targeted Therapy
Olamide Tosin Olaoba, Temitope Isaac Adelusi, Ming Yang, et al.
Cancers (2024) Vol. 16, Iss. 10, pp. 1808-1808
Open Access | Times Cited: 7
Olamide Tosin Olaoba, Temitope Isaac Adelusi, Ming Yang, et al.
Cancers (2024) Vol. 16, Iss. 10, pp. 1808-1808
Open Access | Times Cited: 7
NAMPT Inhibitor and P73 Activator Represses P53 R175H Mutated HNSCC Cell Proliferation in a Synergistic Manner
Bi‐He Cai, Zhi-Yu Bai, Ching‐Feng Lien, et al.
Biomolecules (2022) Vol. 12, Iss. 3, pp. 438-438
Open Access | Times Cited: 10
Bi‐He Cai, Zhi-Yu Bai, Ching‐Feng Lien, et al.
Biomolecules (2022) Vol. 12, Iss. 3, pp. 438-438
Open Access | Times Cited: 10
Identification of TPI1 As a potential therapeutic target in pancreatic cancer with dependency of TP53 mutation using multi‐omics analysis
Tomoaki Toyoda, Nami Miura, Shingo Kato, et al.
Cancer Science (2024)
Open Access | Times Cited: 1
Tomoaki Toyoda, Nami Miura, Shingo Kato, et al.
Cancer Science (2024)
Open Access | Times Cited: 1
Effects of chloroquine and hydroxychloroquine on the sensitivity of pancreatic cancer cells to targeted therapies
James A. McCubrey, Stephen L. Abrams, Matilde Y. Follo, et al.
Advances in Biological Regulation (2022) Vol. 87, pp. 100917-100917
Open Access | Times Cited: 5
James A. McCubrey, Stephen L. Abrams, Matilde Y. Follo, et al.
Advances in Biological Regulation (2022) Vol. 87, pp. 100917-100917
Open Access | Times Cited: 5
